Skip to main content

Table 1 Comparison of histopathological and clinical findings between PACM and no PACM groups of the case–control study

From: Clinicopathological characteristics of pancreatic acinar cell metaplasia associated with Helicobacter pylori infection

 

PACM group (n = 10)

no PACM group (n = 30)

P-value*

A2

   

Inflammation

2.3 ± 0.46

2.8 ± 0.48

0.003

Activity

1 ± 0.63

1.37 ± 0.71

0.14

Atrophy

1.1 ± 0.7

1.37 ± 0.91

0.48

IM

0.3 ± 0.64

0.77 ± 1.12

0.27

B2

   

Inflammation

1.8 ± 0.6

2.6 ± 0.55

0.001

Activity

1 ± 0.89

1.13 ± 0.56

0.39

Atrophy

0.22 ± 0.42

0.5 ± 0.72

0.3

IM

0 ± 0

0.06 ± 0.36

0.56

Endoscopic atrophy

2.2 ± 1.25

3.6 ± 1.58

0.02

Serum gastrin (pg/mL)

145 ± 102.2

202 ± 112.4

0.08

  1. Data are shown as mean scores ± standard error
  2. PACM, pancreatic acinar cell metaplasia; IM, Intestinal metaplasia; USS, updated Sydney System; A2, the greater curvature of the antrum; B2, the greater curvature of the corpus
  3. *P-value were calculated by the Mann–Whitney U-test
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us